Skip to main content

and
  1. No Access

    Article

    Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients

    The aim of this study was to analyse the experience of Polish Pediatric Group for Hematopoietic Stem Cell Transplantation in respect to donor lymphocyte infusion procedure. The study included 51 pediatric pati...

    J Gozdzik, K Rewucka, A Krasowska-Kwiecien, A Pieczonka in Bone Marrow Transplantation (2015)

  2. No Access

    Article

    Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing’s sarcoma

    According to the published report on current practice of hematopoietic SCT in Europe, high-dose therapy (HDT) with autologous stem cell support is a standard of care in paediatric patients with high risk (HR) ...

    K Drabko, A Raciborska, K Bilska, J Styczynski, M Ussowicz in Bone Marrow Transplantation (2012)

  3. No Access

    Article

    Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy

    Our previously published study showed promising results of autologous stem cell transplantation (ASCT) in patients with primary resistant Hodgkin's disease (HD). Probabilities of overall survival (OS) and prog...

    J Czyz, R Szydlo, W Knopinska-Posluszny, A Hellmann in Bone Marrow Transplantation (2004)

  4. No Access

    Article

    High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group

    We analysed the treatment outcome of primary refractory HD patients managed with high-dose chemotherapy and haematopoietic cell transplantation. Data of 65 adult patients who underwent HDC/ASCT in nine Polish ...

    J Czyż, A Hellmann, R Dziadziuszko, J Hansz, J Goździk in Bone Marrow Transplantation (2002)